Phaos Technology Holdings (Cayman) (POAS) Retained Earnings (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Retained Earnings of -$13.7 million for Q4 2025, down 1598855.34% on a QoQ basis from -$855.08 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Retained Earnings (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Retained Earnings history runs 2 years deep, the most recent figure standing at -$13.7 million for Q4 2025.
- Quarterly Retained Earnings changed N/A year-over-year to -$13.7 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was -$13.7 million (changed N/A YoY) and the FY2025 annual result came in at -$12.2 million, down 133.1% from the prior year.
- Retained Earnings was -$13.7 million for Q4 2025 at Phaos Technology Holdings (Cayman), down from -$855.08 in the prior quarter.
- Across five years, Retained Earnings topped out at -$855.08 in Q2 2025 and bottomed at -$13.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.81 Bn | 175.52 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 128.98 Bn | 126.10 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 68.36 Bn | 66.91 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 47.70 Bn | 44.03 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 28.67 Bn | 27.55 Bn | 750.30 Mn | 2.63 Bn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -1.40 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | 5.32 Bn |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | - |
| 10 | Phaos Technology Holdings (Cayman) | 6.17 Mn | 6.12 Mn | - | -13.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -13.67 Mn |
| Apr 30, 2025 | -855.08 |
| Apr 30, 2024 | -5.22 Mn |